loadpatents
name:-0.048362970352173
name:-0.028433084487915
name:-0.00046086311340332
Urbahns; Klaus Patent Filings

Urbahns; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Urbahns; Klaus.The latest application filed is for "2-phenoxy- and 2-phenylsulfonamide derivatives with ccr3 antagonistic activity for the treatment of inflammatory or immunological disorders".

Company Profile
0.23.36
  • Urbahns; Klaus - Lund SE
  • Urbahns; Klaus - Hyogo-ken JP
  • Urbahns; Klaus - Hyogo JP
  • Urbahns; Klaus - Wuppertal DE
  • Urbahns, Klaus - Kyoto JP
  • Urbahns, Klaus - Nada-ku JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
Grant 9,206,186 - Li , et al. December 8, 2
2015-12-08
2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
App 20140005176 - Li; Yingfu ;   et al.
2014-01-02
Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
Grant 8,242,118 - Li , et al. August 14, 2
2012-08-14
Tetrahydro-naphthalene derivatives
Grant 8,173,841 - Tajimi , et al. May 8, 2
2012-05-08
Fused azole-pyrimidine derivatives
Grant 8,129,386 - Shimada , et al. March 6, 2
2012-03-06
Tetrahydro-naphthalene derivatives
Grant 8,088,826 - Tajimi , et al. January 3, 2
2012-01-03
Tetrahydro-naphthalene Derivatives
App 20110178088 - Tajimi; Masaomi ;   et al.
2011-07-21
Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
Grant 7,960,393 - Ly , et al. June 14, 2
2011-06-14
Substituted Heterocycles
App 20110015248 - STADLER; Marc ;   et al.
2011-01-20
Pyrimidine Derivatives Useful For The Treatment Of Diseases Mediated By Crth2
App 20100322980 - Ly; Tai-wei ;   et al.
2010-12-23
Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
Grant 7,812,160 - Ly , et al. October 12, 2
2010-10-12
Arylsulfonamide Derivatives For Use As Ccr3 Antagonists In The Treatment Of Inflammatory And Immunological Disorders
App 20100204213 - LI; Yingfu ;   et al.
2010-08-12
Imidazo[1,2-C]pyrimidinylacetic acid derivatives
Grant 7,750,014 - Ly , et al. July 6, 2
2010-07-06
Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
Grant 7,700,586 - Li , et al. April 20, 2
2010-04-20
2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
Grant 7,674,797 - Li , et al. March 9, 2
2010-03-09
2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
App 20090286771 - Li; Yingfu ;   et al.
2009-11-19
Tetrahydro-naphthalene and urea derivatives
Grant 7,615,557 - Bouchon , et al. November 10, 2
2009-11-10
Hydroxy tetrahydro-naphthalenylurea derivatives
Grant 7,612,113 - Yura , et al. November 3, 2
2009-11-03
Fused Azole-pyrimidine Derivatives
App 20090270388 - Shimada; Mitsuyuki ;   et al.
2009-10-29
Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists
App 20090209514 - Tajimi; Masaomi ;   et al.
2009-08-20
Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
Grant 7,544,716 - Tajimi , et al. June 9, 2
2009-06-09
Fused azole-pyrimidine derivatives
Grant 7,511,041 - Shimada , et al. March 31, 2
2009-03-31
Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives
App 20090012102 - Ly; Tai-wei ;   et al.
2009-01-08
Tetrahydro-naphthalene Derivatives
App 20080275047 - Tajimi; Masaomi ;   et al.
2008-11-06
Hydroxy-tetrahydro-naphthalenylurea derivatives
Grant 7,423,175 - Yura , et al. September 9, 2
2008-09-09
Tetrahydro-naphthalene derivatives
Grant 7,381,840 - Tajimi , et al. June 3, 2
2008-06-03
Bicyclic Amide, Carbamate or Urea Derivatives as Vanilloid Receptor Modulators
App 20080058377 - Mogi; Muneto ;   et al.
2008-03-06
Tetradydro-Naphthalene And Urea Derivatives
App 20080045546 - Bouchon; Axel ;   et al.
2008-02-21
Tetrahydro-naphthalene and urea derivatives
App 20070167458 - Bouchon; Axel ;   et al.
2007-07-19
2-Phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
App 20070155725 - Li; Yingfu ;   et al.
2007-07-05
Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
App 20070129355 - Ly; Tai-wei ;   et al.
2007-06-07
Hydroxy-tetrahydro-naphthalenylurea derivatives
App 20070027187 - Yura; Takeshi ;   et al.
2007-02-01
Hydroxy tetrahydro-naphthalenylurea derivatives
App 20060258742 - Yura; Takeshi ;   et al.
2006-11-16
Substituted heterocycles
App 20060229353 - Stadler; Marc ;   et al.
2006-10-12
Biphenyl and biphenyl-analogous compounds as integrin antagonists
Grant 7,094,911 - Albers , et al. August 22, 2
2006-08-22
2-naphthamide derivatives
App 20060166989 - Shimazaki; Makoto ;   et al.
2006-07-27
Carboxamides derivatives
App 20060135613 - Shimazaki; Makoto ;   et al.
2006-06-22
Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
App 20060135505 - Tajimi; Masaomi ;   et al.
2006-06-22
Tetrahydro-naphthalene derivatives
App 20060128704 - Tajimi; Masaomi ;   et al.
2006-06-15
Fused azole-pyrimidine derivatives
App 20060128732 - Shimada; Mitsuyuki ;   et al.
2006-06-15
Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
App 20060089371 - Murata; Toshiki ;   et al.
2006-04-27
Urea derivatives
App 20050154230 - Yura, Takeshi ;   et al.
2005-07-14
Urea derivatives
App 20050119304 - Yura, Takeshi ;   et al.
2005-06-02
Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
App 20050070582 - Li, Yingfu ;   et al.
2005-03-31
Amine derivatives
App 20040259875 - Yura, Takeshi ;   et al.
2004-12-23
Stents with vitronectin receptor antagonists against restenosis
App 20040236413 - Urbahns, Klaus ;   et al.
2004-11-25
Propionic acid derivatives
App 20040176445 - Urbahns, Klaus ;   et al.
2004-09-09
Propionic acid derivatives
Grant 6,750,236 - Urbahns , et al. June 15, 2
2004-06-15
New biphenyl and biphenyl-analogous compounds as integrin antagonists
App 20040030132 - Albers, Markus ;   et al.
2004-02-12
Biphenyl and biphenyl-analogous compounds as integrin antagonists
Grant 6,677,360 - Albers , et al. January 13, 2
2004-01-13
Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents
App 20030207865 - Dixon, Brian R. ;   et al.
2003-11-06
Propionic acid derivatives
App 20030187041 - Urbahns, Klaus ;   et al.
2003-10-02
Propionic acid derivatives
App 20030032671 - Urbahns, Klaus ;   et al.
2003-02-13
Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
Grant 6,353,006 - Dixon , et al. March 5, 2
2002-03-05
Biphenyl and biphenyl-analogous compounds as integrin antagonists
App 20020016461 - Albers, Markus ;   et al.
2002-02-07
Use of triphenylmethyl-1,2,3-triazoles
App 20010011137 - Urbahns, Klaus ;   et al.
2001-08-02
Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
Grant 6,194,428 - Urbahns , et al. February 27, 2
2001-02-27
Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as medicaments
Grant 5,756,515 - Urbahns , et al. May 26, 1
1998-05-26
Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
Grant 5,670,525 - Urbahns , et al. September 23, 1
1997-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed